Form EFFECT LENZ Therapeutics, Inc.
| UNITED STATES | |
| SECURITIES AND EXCHANGE COMMISSION | |
| Washington, D.C. 20549 | |
| Notice of Effectiveness | |
| Effectiveness Date: | April 10, 2024 4:00 P.M. |
| Form: | S-1 | ||||||
| |||||||
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- LENZ Therapeutics licenses VIZZ eye drop to Arrotex for Australia, NZ
- Could the Bonk Price Prediction Be Missing the One Presale That Turns $500 Into Generational Wealth?
- Next Pepe Coin With Potential Gains Momentum as BTC Crashes Below $60K and DOGE and SHIB Stall
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share